Covalon Technologies (OTCMKTS:CVALF) Shares Down 4%

Shares of Covalon Technologies Ltd. (OTCMKTS:CVALF) were down 4% during trading on Friday . The company traded as low as $0.77 and last traded at $0.77. Approximately 2,568 shares traded hands during mid-day trading, a decline of 46% from the average daily volume of 4,722 shares. The stock had previously closed at $0.81.

Covalon Technologies Stock Performance

The firm has a market cap of $19.36 million, a PE ratio of -5.15 and a beta of -0.51. The stock’s 50 day simple moving average is $0.81 and its 200 day simple moving average is $0.86.

Covalon Technologies (OTCMKTS:CVALF) last posted its quarterly earnings results on Wednesday, February 28th. The company reported ($0.02) EPS for the quarter. Covalon Technologies had a negative net margin of 19.70% and a negative return on equity of 24.83%. The firm had revenue of $3.43 million for the quarter.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.